Related Experiment Video
Updated: Aug 5, 2026

13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Merkel cell carcinoma: an updated guide for pathologists
Paul W Harms1,2,3,4
1Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Histopathology
|August 3, 2026
Summary
Merkel cell carcinoma (MCC) diagnosis is challenging due to its aggressive nature and potential for misdiagnosis. This review highlights diagnostic pitfalls and recent advances, including new markers, to improve accuracy for this rare skin cancer.
Area of Science:
- Dermatopathology
- Oncology
- Diagnostic Pathology
Background:
- Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer with increasing incidence.
- Prompt diagnosis is crucial due to high risks of recurrence, metastasis, and mortality.
- Accurate diagnosis can be difficult, especially with limited samples or unusual presentations.
Purpose of the Study:
- To review diagnostic challenges and nuances in Merkel cell carcinoma.
- To provide an updated differential diagnosis for MCC.
- To discuss the utility of traditional and novel diagnostic markers.
Main Methods:
- Review of literature on Merkel cell carcinoma diagnosis.
- Analysis of differential diagnostic considerations.
- Evaluation of immunohistochemical and molecular markers.
Main Results:
- MCC diagnosis can be confused with other small cell malignancies and cutaneous carcinomas.
- Immunohistochemical overlap exists with vulvar small cell carcinoma and WNT/Beta-catenin-activated nonpilomatrical carcinoma.
- New markers (SATB2, H3K27me3, POU4F3) and traditional markers (CK20, TTF1, neurofilament, Merkel cell polyomavirus) have specific utilities and caveats.
Conclusions:
- Accurate Merkel cell carcinoma diagnosis requires careful consideration of differential diagnoses and marker interpretation.
- Recent advances in markers and molecular analysis aid in achieving a more definitive diagnosis.
- Addressing diagnostic pitfalls is essential for timely management of this aggressive skin cancer.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

